Start the conversation
There's a 76.2% chance that the U.S. Senate will change hands today - and if it does, that's good news for certain tech stocks.
Now, the prediction about the Senate isn't my own - it comes from Nate Silver, an eerily accurate, tech-centric election forecaster.
Silver burst on the national political scene in 2008 with an elaborate computer model that showed Barack Obama winning in a landslide. And he was on the money in 2012, too, predicting almost exactly how much Mitt Romney would lose by.
This Republican surge is good news for tech investors if they want to profit from the big changes brewing in Washington.
So that's why I'm telling you now about three tech stocks that will dominate if the Senate turns Republican after the polls close tonight...
Focus on the Facts
Technology is, by definition, apolitical. After all, a smartphone doesn't know if you're a Democrat, a Republican, or an independent. It either works well or it doesn't.
But here's why I'm talking about politics today.
Political change almost always means winners and losers. And my job is to help you make money in any environment.
First off, however, we can't let our own political passions mislead us. That's something I've learned personally during my 30+ years as a technology investor.
If your hatred for Ronald Reagan in the 1980s or Obama in the 2010s kept you on the sidelines as an investor, you missed two huge bull markets.
Silver's work is so admirable not only because of its focus on the facts, but also due to the complex methodology he employs to get the most accurate predictions. He shares those forecasts at FiveThirtyEight.com, where he is editor in chief.
Silver has formerly worked with The New York Times and the polling firm Rasmussen Reports. But he's now with ESPN.
That new affiliation with the sports broadcaster is appropriate, because he got his start in sabermetrics, empirical baseball statistics analysis. Think Moneyball.
In the political world, Silver already has the equivalent of two perfect games. In 2008, his model correctly called 49 out of 50 states. He missed only Indiana, which Obama captured by just 0.1%.
Then in 2012, he did even better. He correctly forecast 50 out of 50 states. The night before the election, he saw momentum shifting to President Obama in Florida and made the correct call.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.